Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 429.50
-5.75 (-1.32%)
At close: Nov 6, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 43.07 billion as of November 6, 2026. It is the 14,858th most valuable company in the world and the 901st biggest in India. Its market cap has increased by 31.45% in one year.
Market Cap
43.07B
Enterprise Value
46.50B
Revenue
9.81B
Global Rank
Country Rank
#901 India
PE Ratio
58.66
ChartMarket Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 43.07B, an increase of 11,960.21%. That is a compound annual growth rate of 20.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 43.07B | 27.54% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Procter & Gamble Health | 92.04B |
| Sanofi India | 75.61B |
| Bliss GVS Pharma | 64.16B |
| FDC Limited | 63.49B |
| Morepen Laboratories | 50.41B |
| Evonile Pharma | 43.52B |
| Kwality Pharmaceuticals | 37.82B |
| Unichem Laboratories | 35.41B |